ACE and COVID-19: Moreover, a recent study has shown that Coronavirus disease (COVID-19) patients with hypertension treated with ACE inhibitors and AT1R blockers had different values of viral load and an attenuation of the inflammatory response, likely through the inhibition of IL-6 levels [43].